Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation
Clinical trial NCT03423030 · COMPLETED
Trial details
- NCT number
- NCT03423030
- Sponsor
- Innovative Medicines for Tuberculosis
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-05
- Primary completion
- 2018-03-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.